- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,441GBP
- Report
- August 2026
- 370 Pages
Global
From €5249EUR$5,850USD£4,483GBP
- Report
- August 2026
- 285 Pages
Global
From €5249EUR$5,850USD£4,483GBP
- Report
- August 2026
- 299 Pages
Global
From €5249EUR$5,850USD£4,483GBP
- Report
- August 2026
- 293 Pages
Global
From €5249EUR$5,850USD£4,483GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,441GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,441GBP
- Report
- May 2026
- 182 Pages
Global
From €4037EUR$4,500USD£3,449GBP
- Report
- January 2026
- 180 Pages
Global
From €4037EUR$4,500USD£3,449GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,441GBP
- Report
- March 2026
- 150 Pages
Global
From €2422EUR$2,699USD£2,068GBP
- Report
- August 2026
- 266 Pages
Global
From €5249EUR$5,850USD£4,483GBP
- Report
- November 2025
- 200 Pages
Global
From €7133EUR$7,950USD£6,093GBP
- Report
- November 2025
- 200 Pages
Global
From €7133EUR$7,950USD£6,093GBP
- Report
- March 2026
- 148 Pages
Global
From €2691EUR$2,999USD£2,298GBP
€3588EUR$3,999USD£3,065GBP
- Report
- January 2026
- 290 Pages
Global
From €2243EUR$2,500USD£1,916GBP
- Report
- May 2026
- 145 Pages
Global
From €2691EUR$2,999USD£2,298GBP
€3588EUR$3,999USD£3,065GBP
- Report
- May 2026
- 145 Pages
Global
From €2691EUR$2,999USD£2,298GBP
€3588EUR$3,999USD£3,065GBP
- Report
- April 2026
- 150 Pages
Global
From €2691EUR$2,999USD£2,298GBP
€3588EUR$3,999USD£3,065GBP
- Report
- October 2025
- 160 Pages
Global
From €2835EUR$3,160USD£2,422GBP
€3544EUR$3,950USD£3,027GBP

The Vasodilator market is a segment of the Medical Devices industry that focuses on the development and sale of products used to widen blood vessels. These products are used to treat a variety of conditions, including hypertension, coronary artery disease, and peripheral vascular disease. Vasodilators are typically administered through injection, infusion, or inhalation, and can be used to reduce blood pressure, improve blood flow, and reduce the risk of stroke and heart attack.
The Vasodilator market is highly competitive, with a number of large and small companies offering a variety of products. Major players in the market include Pfizer, Merck, Novartis, and Sanofi, while smaller companies such as Bausch Health, Mylan, and Teva Pharmaceuticals also offer products. Additionally, many generic drug manufacturers produce generic versions of popular vasodilators. Show Less Read more